Contrast Media Market: By Product Type (Iohexol, Iopamidol, Iodixanol, Iopromide, Ioversol, Iomeprol, Gadoteric Acid, Gadobutrol, Gadoxetic Acid, Definity, Optison, and SonoVue/Lumason), By Technology (X-Ray/CT, MRI, and Ultrasound), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Contrast Media Market was valued at USD 6,536.1 million in 2023 and is expected to grow at a CAGR of 6.8% from 2024 to 2030. Contrast Media is utilized in imaging techniques to enhance the difference between body tissues in images. The demand for contrast media is rising due to the need to meet the requirements of these advanced imaging modalities. As medical professionals and researchers strive for more detailed and accurate imaging, the demand for contrast media with specific properties, such as higher iodine concentrations, increases. Furthermore, in addition to the technological advancements in imaging modalities, innovations in imaging equipment, such as digital X-ray systems, also contribute to the demand for contrast media. These advancements enable healthcare providers to capture high-quality images with greater clarity and precision. As a result, the use of digital X-ray systems and other advanced imaging equipment has grown, further fueling the demand for contrast media.

Advancements in imaging technologies are driving a surge in demand for specialized contrast media. This demand presents a clear opportunity for further innovation and refinement in the contrast media industry, catering to the evolving requirements of modern diagnostic imaging. With the augmented prevalence and the rise in the number of cancer cases in both developing and developed economies of the world, it is essential to provide techniques that can aid patients get a diagnosis at the earlier stages. Moreover, the stipulation for diagnostics imaging is at an unsurpassed high, with several types of chronic diseases prevalent globally. For instance, as per the report stated by the Medicare Payment Advisory Commission (MedPAC) to the Center for Medicare and Medicaid Services (CMS), the upsurge in the volume of imaging amenities per medicare beneficiary is the utmost among all other services provided by doctors. However, the challenges associated with this contrast media are patients may porn to adverse reactions such as allergic diseases, asthma, anxiety, skin redness, skin swelling, and dizziness. However, the key opportunities associated with the contrast media market are rising demand for voiding cystourethrography, intravenous urography, and hysterosalpingogram. Geographical expansion by the market players and government incentives for R&D activities create opportunities for the players in the Global Contrast Media market.

Contrast Media Market Key Developments:
  • In February 2022, Beijing Beilu Pharmaceutical's Lopamidal approved the Constancy Evaluation for generic drugs. The appraisal aids in look over the quality and efficacy of generic drugs in association with the brand version of the drug.

Global Contrast Media Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.8%

Largest Market

Asia-Pacific

Fastest Growing Market

North America
Contrast Media Market Dynamics

The increasing demand for contrast CTs, angiography, venography developed, and emerging countries is a key factor in the surge of the global contrast media market over the forecast years.  The key factors for the development of the contrast media market contain the rise in the incidences of chronic diseases, increasing demand for image-guided procedures and diagnostics, and an enormous number of approvals for contrast agents. Image-guided processes can help determine if a cancer is malignant or benign. The adult peoples pose a greater danger of chronic conditions with multiple comorbidities. The national Council on Aging report advocates that approximately 82% of people aged 65 and above suffer from at least one chronic condition, with almost 70% of medicare beneficiaries suffering from more than two chronic conditions, and nearly 78.32 million folks in the US are anticipated to be aged 62 and above by 2035. For instance, as per the report stated by the American Heart Association, the incidence of heart failure is increasing in the US and it is one of the primary causes of death in the economies. In 2021, approximately 665,000 folks died owing to cardiovascular diseases in the US by 2030, the number of patients with heart diseases is predicted to rise by 47%.

Global Contrast Media Market Segmentation

By Product Type
  • Iohexol
  • Iopamidol
  • Iodixanol
  • Iopromide
  • Ioversol
  • Iomeprol
  • Gadoteric Acid
  • Gadobutrol
  • Gadoxetic Acid
  • Definity
  • Optison
  • SonoVue/Lumason
By Technology
  • X-Ray/CT
  • MRI
  • Ultrasound
By Geography
  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

The global contrast media market was valued at USD 6,536.1 million in 2023 and is anticipated to grow at a CAGR of 6.8% to reach USD 9,682.0 million by 2029.

Jodas Expoim Pvt. Ltd., GE HealthCare, Unijules Life Sciences Ltd., JB Pharma, Bracco, Lantheus, Sanochemia Pharmazeutika GmbH, TAEJOON Pharmaceutical Co., Ltd., Guerbet, Bayer AG, Spago Nanomedical AB, M. Biotech Limited, Fuji Pharma Co., Ltd., Trivitron Healthcare, Subhra Pharma, Beijing Beilu Pharmaceuticals Co. Ltd., and Jiangsu Hengrui Pharmaceutical Co., Ltd.,

The Contrast Media Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1.Executive Summary
2.Global Contrast Media Market Introduction 
2.1.Global Contrast Media Market  - Taxonomy
2.2.Global Contrast Media Market  - Definitions
2.2.1.Type 
2.2.2.Application
2.2.3.Region
3.Global Contrast Media Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Contrast Media Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Contrast Media Market  By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Iohexol
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Iopamidol
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Iodixanol
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Iopromide
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Ioversol
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Iomeprol
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Gadoteric Acid
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. Gadobutrol
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
5.9. Gadoxetic Acid
5.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.9.3. Market Opportunity Analysis 
5.10. Definity
5.10.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.10.3. Market Opportunity Analysis 
5.11. Optison
5.11.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.11.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.11.3. Market Opportunity Analysis 
5.12. SonoVue/Lumason
5.12.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.12.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.12.3. Market Opportunity Analysis 
6.Global Contrast Media Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. X-Ray/CT
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. MRI
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Ultrasound
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Contrast Media Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Contrast Media Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Iohexol
8.1.2.Iopamidol
8.1.3.Iodixanol
8.1.4.Iopromide
8.1.5.Ioversol
8.1.6.Iomeprol
8.1.7.Gadoteric Acid
8.1.8.Gadobutrol
8.1.9.Gadoxetic Acid
8.1.10.Definity
8.1.11.Optison
8.1.12.SonoVue/Lumason
8.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.X-Ray/CT
8.2.2.MRI
8.2.3.Ultrasound
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Contrast Media Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Iohexol
9.1.2.Iopamidol
9.1.3.Iodixanol
9.1.4.Iopromide
9.1.5.Ioversol
9.1.6.Iomeprol
9.1.7.Gadoteric Acid
9.1.8.Gadobutrol
9.1.9.Gadoxetic Acid
9.1.10.Definity
9.1.11.Optison
9.1.12.SonoVue/Lumason
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.X-Ray/CT
9.2.2.MRI
9.2.3.Ultrasound
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Contrast Media Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Iohexol
10.1.2.Iopamidol
10.1.3.Iodixanol
10.1.4.Iopromide
10.1.5.Ioversol
10.1.6.Iomeprol
10.1.7.Gadoteric Acid
10.1.8.Gadobutrol
10.1.9.Gadoxetic Acid
10.1.10.Definity
10.1.11.Optison
10.1.12.SonoVue/Lumason
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.X-Ray/CT
10.2.2.MRI
10.2.3.Ultrasound
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Contrast Media Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Iohexol
11.1.2.Iopamidol
11.1.3.Iodixanol
11.1.4.Iopromide
11.1.5.Ioversol
11.1.6.Iomeprol
11.1.7.Gadoteric Acid
11.1.8.Gadobutrol
11.1.9.Gadoxetic Acid
11.1.10.Definity
11.1.11.Optison
11.1.12.SonoVue/Lumason
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.X-Ray/CT
11.2.2.MRI
11.2.3.Ultrasound
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Contrast Media Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Iohexol
12.1.2.Iopamidol
12.1.3.Iodixanol
12.1.4.Iopromide
12.1.5.Ioversol
12.1.6.Iomeprol
12.1.7.Gadoteric Acid
12.1.8.Gadobutrol
12.1.9.Gadoxetic Acid
12.1.10.Definity
12.1.11.Optison
12.1.12.SonoVue/Lumason
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.X-Ray/CT
12.2.2.MRI
12.2.3.Ultrasound
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Jodas Expoim Pvt. Ltd.
13.2.2.GE HealthCare
13.2.3.Unijules Life Sciences Ltd.
13.2.4.JB Pharma
13.2.5.Bracco
13.2.6.Lantheus
13.2.7.Sanochemia Pharmazeutika GmbH
13.2.8.TAEJOON Pharmaceutical Co., Ltd.
13.2.9.Guerbet
13.2.10.Bayer AG
13.2.11.Spago Nanomedical AB
13.2.12.Biotech Limited
13.2.13.Fuji Pharma Co., Ltd
13.2.14.Trivitron Healthcare
13.2.15.Subhra Pharma
13.2.16.Beijing Beilu Pharmaceuticals Co. Ltd.
13.2.17.Jiangsu Hengrui Pharmaceutical Co., Ltd.
14. Research Methodology 
15. Appendix and Abbreviations 
  • Jodas Expoim Pvt. Ltd.
  • GE HealthCare
  • Unijules Life Sciences Ltd.
  • JB Pharma
  • Bracco
  • Lantheus
  • Sanochemia Pharmazeutika GmbH
  • TAEJOON Pharmaceutical Co., Ltd.
  • Guerbet
  • Bayer AG
  • Spago Nanomedical AB
  • Biotech Limited
  • Fuji Pharma Co., Ltd
  • Trivitron Healthcare
  • Subhra Pharma
  • Beijing Beilu Pharmaceuticals Co. Ltd.
  • Jiangsu Hengrui Pharmaceutical Co., Ltd.

Adjacent Markets